Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSONALising Factor VIII prophylaxis regimens (PERSONAL trial)
2013-003240-23Phase 4Terminated
- Sponsor
- St James's Hospital
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of octocog alfa in hemophilia A (2 arms), sponsored by St James's Hospital. Primary endpoint: Number of bleeding events. Started Oct 2013; status: terminated.
02
Drugs
octocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2013-003240-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003240-23.